Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The observational study will check if there is a difference in the postoperative care of patients with urogenital intervention while using the standard PCA-syringe pump or using the Zalviso sufentanyl sublingual analgetic system.
The study will exactly examine, using questionaire for the patient, the medical stuff (nurses and anesthesiologist) the difference in the analgetic quality, the difference of the patients' mobility while being treated with one of the analgetic system and if there is a difference in the cost-efficiency.
We want to examine 50 Patients in each group. The studies should be finished in about one year.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients treated with conventional i.v. PCA | |||
| Patients treated with Zalviso |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sufentanil | Drug | Sufentail sublingual 15ug nanopills |
|
| Measure | Description | Time Frame |
|---|---|---|
| analgesic quality | Recording of the analgesic quality measured by the request of more analgesic postoperative while being treated with the conventional PCA or the Zalviso system. | 1 year |
| mobility | Recording of the patients mobility postoperative while being treated with the conventional PCA or the Zalviso system. | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| medical cost efficiency | Comparison of the cost efficiency of both systems | 1 year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
All patients at the teaching hospital of university tuebingen which get an surgical urological intervention and which correspond with the inclusion criteria.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Barbara Schlisio, Dr. med. | Contact | 07071/2985612 | barbara.schlisio@med.uni-tuebingen.de | |
| Fabian Kreß | Contact | Fabian.kress@student.uni-tuebingen.de |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Tuebingen, clinic of anästhesiology and intensiv care | Recruiting | Tübingen | 72074 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017409 | Sufentanil |
| ID | Term |
|---|---|
| D005283 | Fentanyl |
| D010880 | Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided